- Home
- MHUA vs TLPH Comparison
MHUA vs TLPH Comparison
Compare MHUA & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MHUA
- TLPH
- Stock Information
- Founded
- MHUA 1990
- TLPH 2005
- Country
- MHUA China
- TLPH United States
- Employees
- MHUA N/A
- TLPH N/A
- Industry
- MHUA Medical Specialities
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- MHUA Health Care
- TLPH Health Care
- Exchange
- MHUA Nasdaq
- TLPH Nasdaq
- Market Cap
- MHUA 19.6M
- TLPH 10.6M
- IPO Year
- MHUA 2022
- TLPH 2011
- Fundamental
- Price
- MHUA $0.42
- TLPH $0.45
- Analyst Decision
- MHUA
- TLPH Strong Buy
- Analyst Count
- MHUA 0
- TLPH 1
- Target Price
- MHUA N/A
- TLPH $6.00
- AVG Volume (30 Days)
- MHUA 157.0K
- TLPH 42.9K
- Earning Date
- MHUA 04-25-2025
- TLPH 08-13-2025
- Dividend Yield
- MHUA N/A
- TLPH N/A
- EPS Growth
- MHUA N/A
- TLPH N/A
- EPS
- MHUA 0.40
- TLPH N/A
- Revenue
- MHUA $96,909,642.00
- TLPH $27,000.00
- Revenue This Year
- MHUA N/A
- TLPH N/A
- Revenue Next Year
- MHUA N/A
- TLPH $14,533.26
- P/E Ratio
- MHUA $1.10
- TLPH N/A
- Revenue Growth
- MHUA N/A
- TLPH N/A
- 52 Week Low
- MHUA $0.25
- TLPH $0.43
- 52 Week High
- MHUA $1.47
- TLPH $1.19
- Technical
- Relative Strength Index (RSI)
- MHUA 53.34
- TLPH 45.62
- Support Level
- MHUA $0.39
- TLPH $0.45
- Resistance Level
- MHUA $0.46
- TLPH $0.52
- Average True Range (ATR)
- MHUA 0.04
- TLPH 0.03
- MACD
- MHUA -0.00
- TLPH -0.00
- Stochastic Oscillator
- MHUA 86.71
- TLPH 35.33
About MHUA Meihua International Medical Technologies Co. Ltd.
Meihua International Medical Technologies Co Ltd is engaged in providing disposable medical devices. It serves hospitals, pharmacies, medical institutions, and medical equipment companies. Its product offerings include a Disposable Medical mask, Disposable ID Bracelet, Disposable Artificial Anal bag, Disposable Catheter, and Electonic pump among others.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.